Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000838

Drug Information
NameFramycetin    
SynonymsAntibiotic produced by Streptomyces decaris. Neomycin B; NEOMYCIN SULFATE; HSDB 3242; Neomycinum; Myacyne; 4-18-00-07476 (Beilstein Handbook Reference); Neomicina; CID8378; Fraquinol; ST075177; Framycetin [INN:BAN:DCF]; Fradiomycin B; CHEBI:7508; LS-96091; Neobrettin; D05140; EINECS 215-766-3; Antibiotique; Neomycine; Prestwick3_000158; 119-04-0; NMY; DB00994; LS-96095; AC1L1QVH; Neolate; BPBio1_000326; C01737; NEOMYCIN AND POLYMYXIN B SULFATES; Neomas; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol; Myciguent; Actiline; Framycetine [INN-French]; 11025-81-3; Endomixin; neomycin; Framicetina; Tuttomycin; Mycifradin; Framycetinum [INN-Latin]; Myacine; Framygen; Neobiotic; D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy; BDG-(1-4)NEB-(5-1)RIB-(3-1)NED; NCGC00179612-01; AB00443887; Framycetine; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-; UNII-I16QD7X297; Vonamycin powder V; 1393-86-8; DB00452; BRN 0101621; Framicetina [INN-Spanish]; EPA Pesticide Chemical Code 006303; PIMAVECORT; C25H50N6O13; Actilin; Neomycin solution; 1405-10-3 (sulfate (salt)); Antibiotic 10676; Neomcin; N1142_SIGMA; 72131_FLUKA; Soframycin; Soframycin Ophthalmic; Neomycinum [INN-Latin]; HMS2089P15; USAF CB-19; EINECS 204-292-2; CCRIS 5462; Neomycin B sulfate; MolPort-003-938-736; BSPBio_000296; Enterfram; UNII-4BOC774388; Neo-Rx; BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside; 1404-04-2; Fradiomycin; Framycetin; Framycetin (INN); Neomin; Caswell No. 595; Fradiomycinum; Nivemycin; Neomicina [DCIT]; C23H46N6O13; Framycetinum; Soframycine; VONAMYCIN; Neo-Fradin; NEOMYCIN B; Neomycine [INN-French]    
Trade NameSoframycin; Sofra-Tulle    
IndicationBacterial infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntibacterial Agents    
CAS NumberCAS 119-04-0
FormularC23H46N6O13    
PubChem Compound IDCID 8378.    
PubChem Substance IDSID 4872.    
ChEBI7508;    
SuperDrug ATC IDD06AX13;    
SuperDrug CAS ID000119040;    
Target30S ribosomal subunitBinder[2]
16S rRNABinder[2]
Ref 1Drug information of Framycetin, 2008 To Reference
Ref 2Antistaphylococcal activity of gentamicin. Minerva Med. 1975 Dec 8;66(84):4505-26. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543